[Immunotherapy II: clinical investigations for the induction and activity of interferon (author's transl)].
This contribution is concerned with the concept of immunotherapy and the search for the new therapeutic agents. Examples given are, aristolochic acid, Poly I:C and Interferon. The results show a clear correlation of in vivo and in vitro activity of Interferon in the case of virus infections (eccema vaccinatum). No certainty could be determined concerning the efficiency of A.S. and Poly I:C, determined concerning the efficiency of A.S. and Poly I:C, if an Interferon-mechanism was anticipated.
D034341:Aristolochic Acids; D004148:Dioxolanes / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology; D007372:Interferons / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D010616:Phenanthrenes / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D012397:Rosette Formation; D014777:Virus Diseases / Q000188:drug therapy / Q000276:immunology
D034341:Aristolochic Acids; D004148:Dioxolanes; D010616:Phenanthrenes; D007372:Interferons; C000228:aristolochic acid I; D011070:Poly I-C
Immunotherapie II: Klinische Studien zum Nachweis von Induktion und Aktivität von Interferon.